Akbar, Bambang V.E.B. Abdillah, Gao, Shuhan, Isreb, Abdullah, Khoder, Mouhamad, da Silva, Marcelo, Dreiss, Cécile A., Royall, Paul G., Gill, Andrea, Bracken, Louise, Tomlin, Stephen, Chalati, Tamim ORCID: https://orcid.org/0000-0002-4253-5754, Jones, Stuart A. and Alhnan, Mohamed A. (2026) One ink for two processes: exploiting rheology to accelerate 3D-printed chewable tablet manufacturing. International Journal of Pharmaceutics, 704:127451. ISSN 0378-5173 (Print), 1873-3476 (Online) (doi:10.1016/j.ijpharm.2026.127451)

	PDF (Author's Accepted Manuscript) 54528 CHALATI_ One_Ink_For_Two_Processes_(AAM)_2026.pdf - Accepted Version Restricted to Repository staff only until 20 September 2027. Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Request a copy
	PDF (VoR) 54528 CHALATI_ One_Ink_For_Two_Processes_(VoR)_2026.pdf - Published Version Restricted to Repository staff only Download (9MB) | Request a copy

Abstract

Personalised medicines are increasingly required in paediatric and hospital pharmacy practice, where licensed preparations may not be suitable. Semi-solid extrusion three-dimensional printing (SSE-3DP) enables the production of these patient-specific dosage forms, including chewable tablets. However, its layer-by-layer fabrication may limit manufacturing speed and routine implementation in time-pressured hospital pharmacy workflows. This study manufactured theophylline-loaded chewable gummy tablets via two routes: conventional SSE-3DP and template-based ink deposition (TID), using an identical printer and without pharmaceutical ink reformulation. The ink was printed directly at a low temperature to produce cylindrical 3DP tablets, whereas in TID, the ink was extruded at a higher temperature into customised pyramidal template cavities. Rheological assessment of the ink under two processing conditions showed that temperature-dependent viscosity behaviour underpinned the distinct manufacturing routes. Following process optimisation, TID shortened the deposition time for gummy tablets to 2–6 s/unit, 7-fold faster than 3DP (14–42 s/unit). When pre-and post-processing were included, total batch completion time per unit was halved. TID tablets met pharmacopeial requirements for weight and content uniformity, showing comparability to 3DP. Distinct drug release profiles were observed for both production methods. Gummy tablets from TID remained physicochemically stable for up to 28 days at 5 and 25 ◦C. However, the differing thermal and post-processing solidification of the two routes may have resulted in distinct drug-release profiles. Overall, this work extends the functionality of the 3D printer and demonstrates a practical strategy for converting the SSE-3DP process into a rapid dispensing workflow for small-batch personalised gummy medicines in hospital pharmacies and point-of-care settings.

Item Type:	Article
Additional Information:	The research was supported by the Indonesian government through LPDP (Lembaga Pengelola Dana Pendidikan/Indonesia Endowment Funds for Education) scholarship.
Uncontrolled Keywords:	additive manufacturing, rheology transformation, process conversion, rapid drug dispensing, individualised therapy
Subjects:	Q Science > Q Science (General) R Medicine > RS Pharmacy and materia medica T Technology > T Technology (General)
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	01 Oct 2026 12:02
URI:	https://gala.gre.ac.uk/id/eprint/54528

Actions (login required)

View Item

Downloads